Biology
Figure S1. Antiproliferative activity of the synthesized heterosteroidal compounds and cisplatin against MCF-7 cells. Cisplatin (cislp) was used as reference drug. Cells were treated with compounds for 72 h and then the viability was assessed by MTT assay. Results were expressed as mean of 3 independent experiments. Table S1 . Agonist effects of compounds on ERE-TK-luciferase activity in MCF-7 cells. The transcriptional activation of reporter was assessed using Promega Luciferase assays. Cells were treated with compounds at 10 nM concentrations. 17β-estradiol (E2) was used as the reference ERα agonist. The results were expressed as the ratio of the firefly luciferase activity to the β-galactosidase activity, and the luciferase activity was relative to that of the cells treated with E2 which was set as 100.
Entry
Luciferase activity, rel. units DMSO 2.0 ± 0.3 3a 6.9 ± 0.7 3b 11.4 ± 1.2 3c 2.1 ± 0.2 3d 2.0 ± 0.2 3e 2.1 ± 0.2 4a 2.2 ± 0.3 4b 2.0 ± 0.2 4c 1.9 ± 0.3 E2 100 ± 11
